Actuate Therapeutics Announces Initiation of a Multicenter
Elraglusib will be combined with FOLFIRINOX alone or with Losartan in multi-center Phase 2 clinical study initiated at Massachusetts General Hospital, Fred...
Source: globenewswire.com
Stay updated with breaking news from Colind Weekes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Elraglusib will be combined with FOLFIRINOX alone or with Losartan in multi-center Phase 2 clinical study initiated at Massachusetts General Hospital, Fred...